CBMNet will come to a close on 29 June 2019 and, therefore, we are no longer accepting new members. If you are already a member, you will still be able to access member-specific content until 29 June; after that date, it will no longer be available.

The intention is for this website to remain as a host for permissible content for the foreseeable future but we will update members on this when we can. This website will not be maintained, however, so we cannot guarantee permanent access.

If you have any questions, then please contact us on

We would like to extend our gratitude to all our members, without whom this network would not have been possible!



  • Pingback: Industrial Biotechnology - innovateuk

  • GlobalAcorn Ltd was founded to make full use of leading edge nanotechnologies and biopharmaceutical agents created by Prof Andrew Miller (King’s College London) and key collaborators over 15 years of active academic research and a research investment of at least £20 million. These are being used to discover and develop advanced therapeutics and diagnostics that will address unmet medical needs in the treatment and management of chronic, high-burden diseases such as cancer, pain, diabetes, and infections.

    GlobalAcorn is unique in its capabilities to discover and develop advanced therapeutics and diagnostics owing to its Bio-Nano approach that makes use of nanoparticle delivery technologies to maximize the efficacy of biopharmaceutical agents for therapy and the potential of imaging agents for diagnostics, while minimizing required posology and side effects in virtually all cases. The Bio-Nano approach is also being extended into the discovery and development of companion diagnostics for disease detection/monitoring and image-guided therapies, technologies that are expected to make significant contributions towards new and future markets in stratified and personalized medicine.

    GlobalAcorn is actively seeking collaborations and opportunities to support research projects, all for mutual benefit.

  • Pingback: Registration now open: Improving export in Industrial Biotechnology and Bioenergy processes: Focus on Efflux Pumps | Crossing Biological Membranes